---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-23-000004"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T23:17:23.348843+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Haemonetics Q3 fiscal 2023 adjusted EPS $0.82, revenue $298.1M; raises full-year guidance

## Summary
- Q3 revenue $298.1M (+2.1% reported, -0.1% organic); GAAP EPS $0.37, adjusted EPS $0.82 vs $0.73 prior year.
- Plasma revenue up 3% reported but down 5% organic; Hospital revenue up 12% reported (+7% organic).
- Fiscal 2023 revenue guidance raised to $1.195B-$1.205B; adjusted EPS guidance raised to $3.45-$3.55.
- Nine-month revenue $891.2M (+5.2% reported, +5.9% organic); operating cash flow $157.3M.

## SEC filing metadata
- accession: 0000313143-23-000004
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314323000004/0000313143-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314323000004/hae-20230207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-23-000004
- JSON: https://secwatch.observer/filing/0000313143-23-000004.json
- Plain text: https://secwatch.observer/filing/0000313143-23-000004.txt

## Key facts
- Earnings Releases
  HAEMONETICS CORP reported financial results for third quarter and nine months ended December 31, 2022.
  - Period: third quarter and nine months ended December 31, 2022
  - Result: reported results
  source text: On February 7, 2023, Haemonetics Corporation issued a press release announcing financial results for the third quarter and nine months ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314323000004/0000313143-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.